A patient with chronic bronchitis exhibits a productive cough and dyspnea. Which physiological change primarily contributes to these symptoms?

A. Increased bronchial diameter: Chronic bronchitis is characterized by obstructive changes that decrease rather than increase the airway lumen. Chronic inflammation leads to wall thickening and smooth muscle hypertrophy, which increases resistance to airflow. This pathological narrowing contributes significantly to the patient’s expiratory effort and dyspnea. B. Alveolar destruction: The breakdown of alveolar walls and loss of elastic recoil are the primary pathophysiological hallmarks of emphysema rather than chronic bronchitis. While both conditions often coexist in COPD, bronchitis specifically involves the conducting airways. Alveolar destruction leads to permanent air trapping and impaired gas exchange. C. Overproduction of surfactant: Surfactant is a lipoprotein that reduces surface tension to prevent alveolar collapse during expiration. In chronic inflammatory lung diseases, surfactant function is often impaired or inhibited by inflammatory exudates rather than being overproduced. Overproduction is not a recognized feature of the bronchitic disease process. D. Decreased ciliary function: Chronic inhalation of irritants causes squamous metaplasia of the epithelium and direct damage to the mucociliary escalator. This impairment prevents the effective clearance of the excess mucus produced by hypertrophied goblet cells. The resulting stasis of secretions leads to the characteristic persistent productive cough.